{"id":13016,"date":"2019-11-01T20:44:09","date_gmt":"2019-11-01T20:44:09","guid":{"rendered":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/?p=13016"},"modified":"2020-06-02T15:16:58","modified_gmt":"2020-06-02T15:16:58","slug":"examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/","title":{"rendered":"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju"},"content":{"rendered":"

In recent years, there have been tremendous advancements made in gastrointestinal cancer research<\/a>, many of them having to do with the development of high-throughput genomics and proteomics technologies and computational power. According to one researcher at Stony Brook University, we are \u201cat the quantum-leap phase to come up with new therapies for cancer.\u201d<\/p>\n

That researcher is Dr. Jingfang Ju, a professor in the Department of Pathology and co-director of the Translational Research Laboratory at Renaissance School of Medicine, Stony Brook University. His group was the first to discover that p53 regulates the expression of certain microRNAs (miRNAs), opening a new frontier in cancer research. He is now investigating miRNAs as cancer biomarkers and therapeutics. To do this, he has set out to understand the impact of epigenetics in cancer chemoresistance mechanisms such as apoptosis, autophagy, cancer stemness, and epithelial-to-mesenchymal transition.<\/p>\n

\u201cWe have discovered a number of tumor-suppressive miRNAs with either reduced or lost expression in colorectal cancer, gastric cancer, and pancreatic cancer,\u201d said Ju. \u201cWe are focusing on design and development of miRNA-based cancer therapeutics.\u201d<\/p>\n

According to Ju, there are a number of unique advantages of using miRNAs as biomarkers and therapeutics for cancer. First, the number of candidate miRNAs is much smaller than protein-coding mRNA transcripts. Second, miRNAs are highly stable, especially in formalin-fixed, paraffin-embedded (FFPE) tissues and bodily fluids. Finally, since the mechanism of drug resistance in cancer is quite complex, single-target strategies often provide limited survival benefit, and tumor cells develop resistance quickly; miRNAs are multi-target entities since they interact with a number of miRNA transcripts. \u201cThis is a dream for anticancer drug development,\u201d said Ju.<\/p>\n

However, miRNA-based therapeutics don\u2019t come without their challenges. \u201cThe major challenge is delivery,\u201d said Ju. \u201cWe have made some novel modifications of miRNA so that they can be delivered vehicle-free to cancer cells in vivo<\/em>. We think this represents a major advancement in miRNA-based therapeutic development.\u201d<\/p>\n

Ju\u2019s lab uses Applied Biosystems TaqMan miRNA Assays and other tools for gene expression<\/a> and sequencing analysis<\/a> that allow them to quantify miRNA expression and verify miRNA-based biomarker or therapeutic candidates.<\/p>\n

\u201cI am looking for a technology platform that is user-friendly, robust, and cost-effective, with a high level of detection sensitivity,\u201d said Ju. \u201cTaqMan Assays have been that for us for over 15 years.\u201d<\/p>\n

Ju hopes to see his miRNA-based therapeutics translated into the clinic in the near future.<\/p>\n

Read the full interview with Jingfang Ju at https:\/\/www.thermofisher.com\/gexscientistspotlight<\/a><\/strong><\/p>\n

Find out more about our comprehensive gene expression solutions at\u00a0https:\/\/www.thermofisher.com\/geneexpression<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

In recent years, there have been tremendous advancements made in gastrointestinal cancer research, many of them having to do with the development of high-throughput genomics and proteomics technologies and computational power. According to one researcher at Stony Brook University, we are \u201cat the quantum-leap phase to come up with new therapies for cancer.\u201d That researcher<\/p>\n","protected":false},"author":1050,"featured_media":13033,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_monsterinsights_skip_tracking":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[54],"tags":[],"division":[],"class_list":{"0":"post-13016","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cancer-research","8":"entry"},"_selected_authors":"","_selected_reviewers":"","acf":[],"yoast_head":"\nExamining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju - Behind the Bench<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju\" \/>\n<meta property=\"og:description\" content=\"In recent years, there have been tremendous advancements made in gastrointestinal cancer research, many of them having to do with the development of high-throughput genomics and proteomics technologies and computational power. According to one researcher at Stony Brook University, we are \u201cat the quantum-leap phase to come up with new therapies for cancer.\u201d That researcher\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/\" \/>\n<meta property=\"og:site_name\" content=\"Behind the Bench\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thermofisher\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-01T20:44:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-02T15:16:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Geoffrey Cassell\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:site\" content=\"@thermofisher\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Geoffrey Cassell\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/\"},\"author\":{\"name\":\"Geoffrey Cassell\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/7b00b858663077efd5f4f50882e67423\"},\"headline\":\"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju\",\"datePublished\":\"2019-11-01T20:44:09+00:00\",\"dateModified\":\"2020-06-02T15:16:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/\"},\"wordCount\":432,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/11\\\/COL110088-jingfang-ju-F.jpg\",\"articleSection\":[\"Cancer Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/\",\"url\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/\",\"name\":\"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju - Behind the Bench\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/11\\\/COL110088-jingfang-ju-F.jpg\",\"datePublished\":\"2019-11-01T20:44:09+00:00\",\"dateModified\":\"2020-06-02T15:16:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/7b00b858663077efd5f4f50882e67423\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/11\\\/COL110088-jingfang-ju-F.jpg\",\"contentUrl\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2019\\\/11\\\/COL110088-jingfang-ju-F.jpg\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.thermofisher.com\\\/blog\\\/behindthebench\\\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#website\",\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/\",\"name\":\"Behind the Bench\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\\\/#\\\/schema\\\/person\\\/7b00b858663077efd5f4f50882e67423\",\"name\":\"Geoffrey Cassell\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ba039d08f412481d2fc8977ea9f9e41d5fa032eb2ae30bf9eff9f8fa2df8eee0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ba039d08f412481d2fc8977ea9f9e41d5fa032eb2ae30bf9eff9f8fa2df8eee0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ba039d08f412481d2fc8977ea9f9e41d5fa032eb2ae30bf9eff9f8fa2df8eee0?s=96&d=mm&r=g\",\"caption\":\"Geoffrey Cassell\"},\"sameAs\":[\"http:\\\/\\\/admin.acceleratingscience.com\\\/behindthebench\"],\"url\":\"https:\\\/\\\/admin.acceleratingscience.com\\\/author\\\/geoffreycassell\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju - Behind the Bench","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/","og_locale":"en_US","og_type":"article","og_title":"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju","og_description":"In recent years, there have been tremendous advancements made in gastrointestinal cancer research, many of them having to do with the development of high-throughput genomics and proteomics technologies and computational power. According to one researcher at Stony Brook University, we are \u201cat the quantum-leap phase to come up with new therapies for cancer.\u201d That researcher","og_url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/","og_site_name":"Behind the Bench","article_publisher":"https:\/\/www.facebook.com\/thermofisher","article_published_time":"2019-11-01T20:44:09+00:00","article_modified_time":"2020-06-02T15:16:58+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg","type":"image\/jpeg"}],"author":"Geoffrey Cassell","twitter_card":"summary_large_image","twitter_creator":"@thermofisher","twitter_site":"@thermofisher","twitter_misc":{"Written by":"Geoffrey Cassell","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#article","isPartOf":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/"},"author":{"name":"Geoffrey Cassell","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/7b00b858663077efd5f4f50882e67423"},"headline":"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju","datePublished":"2019-11-01T20:44:09+00:00","dateModified":"2020-06-02T15:16:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/"},"wordCount":432,"commentCount":0,"image":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg","articleSection":["Cancer Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/","url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/","name":"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju - Behind the Bench","isPartOf":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#primaryimage"},"image":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg","datePublished":"2019-11-01T20:44:09+00:00","dateModified":"2020-06-02T15:16:58+00:00","author":{"@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/7b00b858663077efd5f4f50882e67423"},"breadcrumb":{"@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#primaryimage","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg","contentUrl":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/examining-mirnas-as-cancer-biomarkers-with-dr-jingfang-ju\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admin.acceleratingscience.com\/behindthebench\/"},{"@type":"ListItem","position":2,"name":"Examining miRNAs as Cancer Biomarkers with Dr. Jingfang Ju"}]},{"@type":"WebSite","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#website","url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/","name":"Behind the Bench","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.acceleratingscience.com\/behindthebench\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/admin.acceleratingscience.com\/behindthebench\/#\/schema\/person\/7b00b858663077efd5f4f50882e67423","name":"Geoffrey Cassell","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ba039d08f412481d2fc8977ea9f9e41d5fa032eb2ae30bf9eff9f8fa2df8eee0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ba039d08f412481d2fc8977ea9f9e41d5fa032eb2ae30bf9eff9f8fa2df8eee0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba039d08f412481d2fc8977ea9f9e41d5fa032eb2ae30bf9eff9f8fa2df8eee0?s=96&d=mm&r=g","caption":"Geoffrey Cassell"},"sameAs":["http:\/\/admin.acceleratingscience.com\/behindthebench"],"url":"https:\/\/admin.acceleratingscience.com\/author\/geoffreycassell\/"}]}},"taxonomy_info":{"category":[{"value":54,"label":"Cancer Research"}]},"featured_image_src_large":["https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F-1024x536.jpg",760,398,true],"author_info":{"display_name":"Geoffrey Cassell","author_link":"https:\/\/admin.acceleratingscience.com\/author\/geoffreycassell\/"},"comment_info":0,"category_info":[{"term_id":54,"name":"Cancer Research","slug":"cancer-research","term_group":0,"term_taxonomy_id":54,"taxonomy":"category","description":"","parent":0,"count":142,"filter":"raw","meta":[],"cat_ID":54,"category_count":142,"category_description":"","cat_name":"Cancer Research","category_nicename":"cancer-research","category_parent":0}],"tag_info":false,"jetpack-related-posts":[{"id":19911,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/multiplex-mirna-profiling-precision-oncology\/","url_meta":{"origin":13016,"position":0},"title":"A scalable multiplex miRNA profiling workflow for precision oncology research","author":"Ashleigh Barlow","date":"August 18, 2026","format":false,"excerpt":"The promise of precision oncology rests on our ability to reliably monitor tumor biology in real time. Circulating microRNAs (miRNAs) offer that opportunity, serving as potentially stable, non-invasive biomarkers linked to disease progression and therapeutic response; however, their adoption in routine practice remains constrained by technical hurdles. (1,2) Because cancer\u2026","rel":"","context":"In "Cancer Research"","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Scientist pipetting a laboratory sample during molecular biomarker research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/08\/lisa-blog-picture.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19857,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/mirna-biomarkers-type-1-diabetes\/","url_meta":{"origin":13016,"position":1},"title":"A pan-continental miRNA profiling study powered by TaqMan qPCR reveals potential new biomarkers for Type 1 Diabetes risk","author":"Ashleigh Barlow","date":"July 28, 2026","format":false,"excerpt":"In conversation with Professor Anandwardhan Hardikar Detecting type 1 diabetes (T1D) before major pancreatic damage occurs remains one of the biggest challenges in the field. By the time most patients are diagnosed, a large proportion of insulin-producing islet \u03b2-cells have already been lost. Traditional markers such as blood glucose or\u2026","rel":"","context":"In "Complex Diseases"","block_context":{"text":"Complex Diseases","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/complex-diseases\/"},"img":{"alt_text":"Professor Anandwardhan Hardikar discussing type 1 diabetes biomarker research in front of molecular biology data visualizations.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/07\/hardikar_Lisa-Crawford.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/07\/hardikar_Lisa-Crawford.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/07\/hardikar_Lisa-Crawford.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/07\/hardikar_Lisa-Crawford.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/07\/hardikar_Lisa-Crawford.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/07\/hardikar_Lisa-Crawford.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":19805,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/liquid-biopsy-workflow-standardization\/","url_meta":{"origin":13016,"position":2},"title":"Improving the Reliability of Liquid Biopsy in Real-World Settings Through Workflow Standardization: A Discussion with Dr. Matteo Allegretti","author":"Ashleigh Barlow","date":"June 18, 2026","format":false,"excerpt":"Liquid biopsy offers a powerful, noninvasive way to detect and track cancer, but ensuring reliability in real-world settings remains a key hurdle. Variability in workflows and the need for robust verification steps limit widespread adoption. Dr. Matteo Allegretti, Senior Researcher at the Translational Oncology Research Unit at the IRCCS Regina\u2026","rel":"","context":"In "Cancer Research"","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Research scientist operating laboratory equipment during liquid biopsy and biomarker research.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/06\/Allegretti-Header.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":19232,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/early-molecular-relapse-detection-dpcr\/","url_meta":{"origin":13016,"position":3},"title":"Following the Molecular Fingerprints of Cancer with Digital PCR","author":"Behind The Bench Staff","date":"November 11, 2025","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=vbta1TG617s For clinical researchers and scientists, the value of a biomarker depends on its accurate measurement and trackability over time. Digital PCR (dPCR) delivers both. At Tata Medical Center, Dr. Mayur Parihar, Senior Consultant in Hematology and Cytogenetics and Clinical Research Scientist at the Tata Translational Cancer Research Center, recognizes\u2026","rel":"","context":"In "Cancer Research"","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Pathologist preparing a molecular diagnostic sample in a clinical laboratory to support precision oncology decision-making.","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/LC-Blog_Preferred-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19345,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/precision-oncology-diagnostics\/","url_meta":{"origin":13016,"position":4},"title":"The Expanding Role of Molecular Diagnostics in Precision Oncology","author":"Behind The Bench Staff","date":"January 13, 2026","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=F6FfHIizJBY For Dr. Harald Bartsch, a clinical pathologist in southern Bavaria, molecular diagnostic tools have become an indispensable part of his arsenal. \u201cI believe molecular diagnostics play a crucial role in modern oncology, and I see this as the direction everything is headed,\u201d says Dr. Bartsch. While immunohistochemistry remains central\u2026","rel":"","context":"In "Cancer Research"","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"Clinical Pathologist in a Molecular Diagnostics Laboratory","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/01\/Bartsch-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":19579,"url":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/liquid-biopsy-cancer-research-ngs-pcr\/","url_meta":{"origin":13016,"position":5},"title":"From Discovery to Monitoring: How Sequencing and PCR Work Together in Oncology Research","author":"Behind The Bench Staff","date":"March 24, 2026","format":false,"excerpt":"Scientific, joins the Absolute Gene-ius podcast to discuss how molecular technologies are advancing precision oncology research. With experience spanning clinical laboratory research, digital PCR research applications, and next-generation sequencing (NGS), Dr. Sollweck shares how scientists are addressing critical unmet needs in cancer research. From liquid biopsy research strategies to minimal\u2026","rel":"","context":"In "Cancer Research"","block_context":{"text":"Cancer Research","link":"https:\/\/admin.acceleratingscience.com\/behindthebench\/cancer-research\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2026\/03\/Sollweck-headshot-200x250_Jordan-Ruggieri.jpeg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/admin.acceleratingscience.com\/behindthebench\/wp-content\/uploads\/sites\/9\/2019\/11\/COL110088-jingfang-ju-F.jpg","_links":{"self":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/13016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/users\/1050"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/comments?post=13016"}],"version-history":[{"count":0,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/posts\/13016\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media\/13033"}],"wp:attachment":[{"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/media?parent=13016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/categories?post=13016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/tags?post=13016"},{"taxonomy":"division","embeddable":true,"href":"https:\/\/www.thermofisher.com\/blog\/behindthebench\/wp-json\/wp\/v2\/division?post=13016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}